Phylogica
News published by Phylogica officials updates activities
Published in Biotech Business Week, May 28th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Phylogica.
Report 1: Australian drug development company Phylogica Limited (ASX:PYC) today announced that it has received funding from the Neurotrauma Research Program to develop a new Phylomer drug that will prevent the brain damage associated with traumatic brain injury.
Traumatic Brain Injury (TBI) is caused by the head forcibly hitting an object, such as a car dashboard in a motor vehicle accident. In the United States, the direct cost of care for patients with TBI,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Arthritis
Counseling, Coping Skills Could Reduce Arthritis Disability - Asthma
Ulcerative colitis sufferers find UC quite disruptive to many aspects of daily life - Autoimmune Disease
Natural immune-control system may aid treatment of autoimmune disease and tissue rejection - Breast Cancer
Chemotherapy More Effective When Given Before Breast Cancer Surgery - Breast Cancer
Soy estrogens and breast cancer research reported - Cancer
Scientists Activate New Cancer Drug Using Light and Oxygen - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
